EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial

Line Davidsen iD, Simon Lebech Cichosz iD, Peter Bisgaard Stæhr, Peter Vestergaard, Asbjørn M Drewes, Filip Krag Knop, Morten Hasselstrøm Jensen iD, Søren Schou Olesen

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16356 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Line Davidsen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Glycemic Control, Hypoglycemia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: A.P. Møller and Chastine Mc-Kinney Møller Foundation, Dexcom, Inc, Steno Diabetes Centre North Denmark.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims Continuous glucose monitoring (CGM) improves glycaemic control and reduces hypoglycaemia in type 1 and 2 diabetes, but its role in managing diabetes in chronic pancreatitis is unknown. We aimed to investigate the effect of CGM compared to self‐monitoring of blood glucose (SMBG) on hypoglycaemia and glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes. Materials and Methods In a randomised, open‐label, crossover trial, 30 participants with chronic pancreatitis and insulin‐treated diabetes were randomised to 50 days of CGM or SMBG, separated by a 20‐day washout period. The primary endpoint was time in level 2 hypoglycaemia (10.0 mmol/L; mean difference −6.55%, 95% CI −12.59% to −0.51%; p = 0.04), and reduced time below range (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Glycemic ControlHypoglycemiaHypoglycemic AgentsInsulinPancreatitis, ChronicAgedFemaleHumansMaleMiddle AgedBlood GlucoseBlood Glucose Self-MonitoringContinuous Glucose MonitoringCross-Over StudiesGlycated HemoglobinTreatment Outcome

Stichwörter der Autor:innen

chronic pancreatitiscontinuous glucose monitoringglycaemic controlhypoglycaemiasecondary diabetes

Substanzen

Blood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulin

Autor:innen und Institutionen

  • Centre for Pancreatic Diseases and Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
  • Department of Cardiology, North Denmark Regional Hospital, Hjørring, Denmark.
  • Steno Diabetes Centre North Denmark, Aalborg University Hospital, Aalborg, Denmark.
  • Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.

ORCID-Profile: Line Davidsen, Simon Lebech Cichosz, Morten Hasselstrøm Jensen

Förderung

  • A.P. Møller and Chastine Mc-Kinney Møller Foundation
  • Dexcom, Inc
  • Steno Diabetes Centre North Denmark
  • Heinrich Kopp's Grant
  • Region North Denmark Health Science Research Foundation
  • Dexcom

Zitieren

APA

Davidsen, L., Cichosz, S. L., Stæhr, P. B., Vestergaard, P., Drewes, A. M., Knop, F. K., Jensen, M. H., & Olesen, S. S. (2025). Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16356

Vancouver

Davidsen L, Cichosz SL, Stæhr PB, Vestergaard P, Drewes AM, Knop FK, et al. Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16356

BibTeX
@article{Davidsen2025,
  author = {Davidsen, Line and Cichosz, Simon Lebech and Stæhr, Peter Bisgaard and Vestergaard, Peter and Drewes, Asbjørn M and Knop, Filip Krag and Jensen, Morten Hasselstrøm and Olesen, Søren Schou},
  title = {Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16356}
}
Kostenlos starten →